ClinConnect ClinConnect Logo
Search / Trial NCT05031390

the Horsens Aarhus FemoroAcetabular Impingement Syndrome Training Pilot Study

Launched by HORSENS HOSPITAL · Aug 26, 2021

Trial Information

Current as of May 28, 2025

Unknown status

Keywords

ClinConnect Summary

The aim of this study is to investigate the feasibility of a 12-weeks (progressive) exercise program in patients with FAIS. Feasibility is evaluated on the recruitment strategy, patient adherence to the exercises and their experiences with and motivation for performing exercises. Furthermore, the investigators wish to investigate the variation of data before and after the exercise program to help estimate a suitable sample size for a future randomized controlled trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients aged 18-50 years old
  • 2. Diagnosed with FAIS according to the Warwick agreement
  • 3. Patients having cam morphology should have an alpha angle of \> 55 degrees on an anterior-posterior radiograph.
  • 4. Patients having pincer should have a lateral centre edge angle of \>39 degrees on an anterior-posterior radiograph.
  • 5. Lateral joint space width should be \>3 mm.
  • 6. Body mass index is below 30.
  • 7. Motivated for participation in a 12 week training program with 8 physical attendances.
  • Exclusion Criteria:
  • 1. Received physiotherapist-led treatment in the past 3 months,
  • 2. Previous hip surgery in included hip or other major hip injury,
  • 3. Systemic conditions e.g. rheumatoid arthritis, cancer,
  • 4. Chronical pain syndromes,
  • 5. Unable to perform testing procedures,
  • 6. Unable to attend a 12-week treatment program or baseline and follow-up assessments
  • 7. Contraindications to radiographs (e.g. pregnancy)
  • 8. Unable to read or understand questionnaires and/or instructions

About Horsens Hospital

Horsens Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. With a focus on interdisciplinary collaboration, the hospital leverages its state-of-the-art facilities and a team of experienced healthcare professionals to conduct rigorous studies across various medical fields. Committed to ethical standards and patient safety, Horsens Hospital strives to contribute valuable insights to the scientific community and enhance treatment options for patients. Through its robust clinical trial program, the hospital plays a pivotal role in translating research findings into effective healthcare solutions.

Locations

Patients applied

0 patients applied

Trial Officials

Signe Kierkegaard, PhD

Principal Investigator

Regionshospitalet Horsens

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials